BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 9169639)

  • 41. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
    Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
    J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
    J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone marrow transplantation for leukaemia in Europe.
    Gratwohl A; Hermans J; Lyklema A; Zwaan FE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):353-60. PubMed ID: 2480274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second HLA-identical sibling transplants for leukemia recurrence.
    Mrsíc M; Horowitz MM; Atkinson K; Biggs JC; Champlin RE; Ehninger G; Gajewski JL; Gale RP; Herzig RH; Prentice HG
    Bone Marrow Transplant; 1992 Apr; 9(4):269-75. PubMed ID: 1600415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission.
    De Witte T; Awwad B; Boezeman J; Schattenberg A; Muus P; Raemaekers J; Preijers F; Strijckmans P; Haanen C
    Bone Marrow Transplant; 1994 Nov; 14(5):767-74. PubMed ID: 7889010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone marrow transplantation for primary refractory acute leukaemia.
    Mehta J; Powles R; Horton C; Milan S; Treleaven J; Tait D; Catovsky D
    Bone Marrow Transplant; 1994 Sep; 14(3):415-8. PubMed ID: 7994265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Working Party on Acute Leukemia of the European Cooperative Group for Bone Marrow Transplantation (EMBT).
    Mandelli F; Labopin M; Granena A; Iriondo A; Prentice G; Bacigalupo A; Sierra J; Meloni G; Frassoni F; Goldman J
    Bone Marrow Transplant; 1994 Aug; 14(2):293-8. PubMed ID: 7994245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia?
    Ringdén O; Labopin M; Solders M; Beelen D; Arnold R; Ehninger G; Milpied N; Niederwieser D; Hamladji RM; Kyrcz-Krzemien S; Ganser A; Socié G; Stelljes M; Volin L; Craddock C; Mohty M;
    Transplantation; 2014 Sep; 98(5):569-77. PubMed ID: 24798307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
    Ringdén O; Labopin M; Gorin NC; Schmitz N; Schaefer UW; Prentice HG; Bergmann L; Jouet JP; Mandelli F; Blaise D; Fouillard L; Frassoni F;
    Br J Haematol; 2000 Dec; 111(4):1130-7. PubMed ID: 11167752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Slow response to induction chemotherapy is an indicator of poor survival after bone marrow transplantation for acute lymphoblastic leukemia. The Leukemia Working Party of the European Group of Bone Marrow Transplantation (EBMT).
    Niederwieser D; Granena A; Hermans J; Kolb HJ; Zwaan F; Gratwohl A
    Bone Marrow Transplant; 1992 Jun; 9(6):439-43. PubMed ID: 1628128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO).
    Dini G; Cancedda R; Locatelli F; Bosi A; Bandini G; Alessandrino EP; Porta F; Uderzo C; Messina C; Fagioli F; Arcese W; Marenco P; Fanin R; Falda M; Soligo D; La Nasa G; Giardini C; Pession A; Scimè R; Di Bartolomeo P; Bruno B; Garbarino L; Lamparelli T; Giorgiani G; Lanino E; Manzitti C; Bacigalupo A;
    Haematologica; 2001 May; 86(5):451-6. PubMed ID: 11410406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autologous bone marrow transplantation for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia--a comparison.
    Anderson CC; Goldstone AH; Linch DC; Jones HM; Franklin IM; Boughton BJ; Cawley JC; Richards JD
    Bone Marrow Transplant; 1987 Feb; 1(3):271-9. PubMed ID: 3332138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.
    Perkins HA; Kollman C; Howe CW
    Clin Transpl; 1994; ():295-301. PubMed ID: 7547550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allogeneic bone marrow transplantation for leukemia: factors of importance for long-term survival and relapse.
    Ringdén O; Sundberg B; Lönnqvist B; Tollemar J; Gahrton G; Nilsson B
    Bone Marrow Transplant; 1988 Jul; 3(4):281-90. PubMed ID: 3048493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autologous bone marrow transplantation for acute leukemia: results and prognostic factors in 90 consecutive patients.
    Sierra J; Grañena A; García J; Valls A; Carreras E; Rovira M; Canals C; Martínez E; Puntí C; Algara M
    Bone Marrow Transplant; 1993 Nov; 12(5):517-23. PubMed ID: 8298563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors.
    Schiller G; Feig SA; Territo M; Wolin M; Lill M; Belin T; Hunt L; Nimer S; Champlin R; Gajewski J
    Br J Haematol; 1994 Sep; 88(1):72-8. PubMed ID: 7803259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unrelated donor or autologous marrow transplantation for treatment of acute leukemia.
    Busca A; Anasetti C; Anderson G; Appelbaum FR; Buckner CD; Doney K; Martin PJ; Petersdorf E; Sanders JE; Hansen JA
    Blood; 1994 May; 83(10):3077-84. PubMed ID: 8180404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.